Labcorp Holdings Inc.
Labcorp Holdings Inc. (LH) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · LH · as of Mar 31, 2025
Ownership Breakdown
979
Institutional Holders
▲ 39 vs Q4
$18.11B
Total Inst. Value
▲ $239.58M vs Q4
82.00M
Shares Outstanding
freeFloat 99.60%
77.84M
13F Shares Held
▼ 106,816 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
LH largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC services-medical laboratories | 9.72M | 11.63% | 11.63% | $2.26T | May 9, 2025 | ▲ 71.5K |
BLACKROCK, INC. services-medical laboratories | 9.28M | 11.10% | 11.10% | $2.16T | May 2, 2025 | ▼ 43.6K |
STATE STREET CORP services-medical laboratories | 3.83M | 4.58% | 4.58% | $890.70B | May 15, 2025 | ▲ 123.4K |
SELECT EQUITY GROUP, L.P. services-medical laboratories | 2.22M | 2.66% | 2.66% | $516.70B | May 15, 2025 | ▲ 624.1K |
GEODE CAPITAL MANAGEMENT, LLC services-medical laboratories | 2.07M | 2.47% | 2.47% | $479.92B | May 13, 2025 | ▲ 64.8K |
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC services-medical laboratories | 1.96M | 2.34% | 2.34% | $455.37B | Apr 24, 2025 | ▲ 40.8K |
DIAMOND HILL CAPITAL MANAGEMENT INC services-medical laboratories | 1.95M | 2.33% | 2.33% | $454.21B | May 6, 2025 | ▼ 15.5K |
BANK OF NEW YORK MELLON CORP services-medical laboratories | 1.81M | 2.17% | 2.17% | $421.66B | Apr 29, 2025 | ▼ 11.3K |
FMR LLC services-medical laboratories | 1.73M | 2.07% | 2.07% | $403.61B | May 12, 2025 | ▲ 113.3K |
MORGAN STANLEY services-medical laboratories | 1.58M | 1.88% | 1.88% | $366.61B | May 15, 2025 | ▲ 156.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
28
Increased
+3.21M shares0
New Positions
first time holders22
Decreased
−768.5K shares0
Sold Out
fully exitedNet shares change (top 50)
+2.44M
+3.21M / −768.5K
Net new holders
+6
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
LH insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
1
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Schechter Adam H President & CEO | May 11, 2026 | Sale | 5,903 | $254.50 | $1.50M | 107.2K | Form 4 ↗ |
Schechter Adam H President & CEO | Mar 26, 2026 | Award | 58,470 | — | — | 139.2K | Form 4 ↗ |
Schechter Adam H President & CEO | Mar 26, 2026 | Tax Withhold | 26,106 | $268.38 | $7.01M | 113.1K | Form 4 ↗ |
GRAHAM ANITA Z EVP, CHRO | Mar 26, 2026 | Award | 6,604 | — | — | 8.1K | Form 4 ↗ |
GRAHAM ANITA Z EVP, CHRO | Mar 26, 2026 | Tax Withhold | 2,879 | $268.38 | $772.7K | 5.2K | Form 4 ↗ |
Schroeder Mark S EVP, Pres Diagnostics & COO | Mar 26, 2026 | Award | 9,304 | — | — | 15.8K | Form 4 ↗ |
Schroeder Mark S EVP, Pres Diagnostics & COO | Mar 26, 2026 | Award | 2,968 | — | — | 14.1K | Form 4 ↗ |
Schroeder Mark S EVP, Pres Diagnostics & COO | Mar 26, 2026 | Tax Withhold | 1,468 | $268.38 | $394.0K | 12.7K | Form 4 ↗ |
Schroeder Mark S EVP, Pres Diagnostics & COO | Mar 26, 2026 | Tax Withhold | 4,600 | $268.38 | $1.23M | 11.2K | Form 4 ↗ |
Caveney Brian J EVP, Pres of ED, CMO & CSO | Mar 26, 2026 | Award | 9,304 | — | — | 39.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Labcorp Holdings Inc. (LH) is primarily owned by institutional investors, who hold approximately 94.9% of total shares outstanding. Company insiders own approximately 0.40%, while retail and public investors account for the remaining 4.67%.
The largest institutional shareholder of Labcorp Holdings Inc. is VANGUARD GROUP INC, holding approximately 9.72 million shares — equal to 11.63% of outstanding shares — as of March 31, 2025.
A total of 979 institutional investors currently hold LH stock, with a combined institutional value of approximately $18.11 billion as of the most recent 13F filing period.
Frequently asked questions
LH ownershipLabcorp Holdings Inc. (LH) is primarily owned by institutional investors, who hold approximately 94.9% of shares. The largest shareholder is VANGUARD GROUP INC with a 11.63% stake. Company insiders hold 0.40%. Data sourced from SEC Form 13F as of March 31, 2025.